| Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre … CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ... The Lancet Microbe 2 (8), e354-e365, 2021 | 286 | 2021 |
| Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study RK Gupta, EM Harrison, A Ho, AB Docherty, SR Knight, M van Smeden, ... The Lancet Respiratory Medicine 9 (4), 349-359, 2021 | 208 | 2021 |
| Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the … CI Bloom, TM Drake, AB Docherty, BJ Lipworth, SL Johnston, ... The Lancet Respiratory Medicine, 2021 | 164 | 2021 |
| Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study TM Drake, AM Riad, CJ Fairfield, C Egan, SR Knight, R Pius, ... The Lancet 398 (10296), 223-237, 2021 | 143 | 2021 |
| A prenylated dsRNA sensor protects against severe COVID-19 A Wickenhagen, E Sugrue, S Lytras, S Kuchi, M Noerenberg, ML Turnbull, ... Science 374 (6567), eabj3624, 2021 | 142 | 2021 |
| The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion A Evans, E Costello Frontiers in physiology 3, 270, 2012 | 116 | 2012 |
| Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK AB Docherty, RH Mulholland, NI Lone, CP Cheyne, D De Angelis, ... The Lancet Respiratory Medicine 9 (7), 773-785, 2021 | 98 | 2021 |
| Decreased serum thrombospondin-1 levels in pancreatic cancer patients up to 24 months prior to clinical diagnosis: association with diabetes mellitus C Jenkinson, VL Elliott, A Evans, L Oldfield, RE Jenkins, DP O'Brien, ... Clinical Cancer Research 22 (7), 1734-1743, 2016 | 93 | 2016 |
| Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, ... The Lancet Rheumatology 3 (7), e498-e506, 2021 | 87 | 2021 |
| Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre … G Middleton, DH Palmer, W Greenhalf, P Ghaneh, R Jackson, T Cox, ... The Lancet Oncology 18 (4), 486-499, 2017 | 72 | 2017 |
| S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes T Nedjadi, A Evans, A Sheikh, L Barerra, S Al-Ghamdi, L Oldfield, ... BMC cancer 18 (1), 1255, 2018 | 40 | 2018 |
| Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study F Närhi, SR Moonesinghe, SD Shenkin, TM Drake, RH Mulholland, ... The Lancet Digital Health 4 (4), e220-e234, 2022 | 26 | 2022 |
| Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes L Oldfield, A Evans, RG Rao, C Jenkinson, T Purewal, EE Psarelli, ... EBioMedicine 75, 2022 | 22 | 2022 |
| Fibroblasts from distinct pancreatic pathologies exhibit disease-specific properties LN Barrera, A Evans, B Lane, S Brumskill, FE Oldfield, F Campbell, ... Cancer Research, 2020 | 20 | 2020 |
| F1F0-ATP synthase inhibitory factor 1 in the normal pancreas and in pancreatic ductal adenocarcinoma: effects on bioenergetics, invasion and proliferation H Tanton, S Voronina, A Evans, J Armstrong, R Sutton, D Criddle, ... Frontiers in physiology 9, 833, 2018 | 10 | 2018 |
| The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements M Ashworth, B Small, L Oldfield, A Evans, W Greenhalf, C Halloran, ... Scientific Reports 11 (1), 6487, 2021 | 9 | 2021 |
| Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis M Tsakiroglou, A Evans, M Pirmohamed Frontiers in Genetics 14, 1100352, 2023 | 8 | 2023 |
| hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA K Aughton, NO Elander, A Evans, R Jackson, F Campbell, E Costello, ... Cancers 13 (22), 5758, 2021 | 7 | 2021 |
| Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation R Ferguson, K Aughton, A Evans, V Shaw, J Armstrong, A Ware, ... Current Issues in Molecular Biology 45 (3), 2505-2520, 2023 | 2 | 2023 |
| Biomarker predication of efficacy to gemcitabine plus vandetanib in phase II, double blind multicentre randomised controlled trial of gemcitabine placebo in locally advanced or … A Evans, R Jackson, VE Shaw, P Ghaneh, J Wadsley, JW Valle, H Wasan, ... Pancreatology 18 (4), S127-S128, 2018 | 1 | 2018 |
